Alexander Horn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Horn has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Uli Kazmaier
Saarland University, Organic Chemistry I, Campus, Building C4.2, D-66123 Saarbrücken, Germany
2 shared publications - Agnes-Valencia Weiss
Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology Saarland University Saarbrücken Germany
1 shared publication - Armin Walter Novak
Saarland University, Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Saarbrücken, Germany
1 shared publication - Marc Schneider
Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Saarland University, Campus C4 1, 66123 Saarbrücken, Germany
1 shared publication Stefan V. Pochmann
Department of Pharmacy Biopharmaceutics and Pharmaceutical Technology PharmaScienceHub (PSH) Saarland University 66123 Saarbrücken Germany
1 shared publication
Latest Publications
- Open Access
- 20 February 2025
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 226 (10)
Comparative Analysis of Two Elastic Types of Surface‐Crosslinked Gelatin Nanoparticles as Suitable Systems for Macromolecular Drug Delivery
With a steadily rising number of novel biopharmaceuticals in development, the demand for applicable delivery systems for macromolecular drugs persists. Polymeric nanoparticles, consisting of the natural product gelatin, present beneficial attributes for this application. To stabilize those nanoparticles without interfering with encapsulated macromolecules, surface‐crosslinked gelatin particles are developed and thoroughly characterized for their physicochemical and mechanical properties. With only limited data available for the latter, investigating the elastic properties can offer a more comprehensive understanding of the crosslinking processes involved and of the gelatin particles’ potential applications. In this study, protocols for surface‐crosslinked gelatin particles type A (GNP‐A) and B (GNP‐B) are described. Significant differences between the two types of gelatin are reported regarding their physicochemical and mechanical properties. GNP‐A consists of a lower crosslinking degree, leading to pronounced swelling in aqueous environments and softer nanoparticles. They possess contrary properties compared to the more extensively crosslinked and stiffer GNP‐B. However, this doesn't affect encapsulation efficiency, allowing to develop nanoparticulate systems suitable for various applications by adjusting the particle properties while maintaining the same drug load. These findings provide a deeper understanding of polymeric gelatin particles and reveal the importance of investigating the mechanical properties of drug delivery systems during pharmaceutical development.
- 20 February 2025
- Published by Wiley in Macromolecular Chemistry and Physics
- Vol. 226 (10)
Open AccessComparative Analysis of Two Elastic Types of Surface‐Crosslinked Gelatin Nanoparticles as Suitable Systems for Macromolecular Drug Delivery
With a steadily rising number of novel biopharmaceuticals in development, the demand for applicable delivery systems for macromolecular drugs persists. Polymeric nanoparticles, consisting of the natural product gelatin, present beneficial attributes for this application. To stabilize those nanoparticles without interfering with encapsulated macromolecules, surface‐crosslinked gelatin particles are developed and thoroughly characterized for their physicochemical and mechanical properties. With only limited data available for the latter, investigating the elastic properties can offer a more comprehensive understanding of the crosslinking processes involved and of the gelatin particles’ potential applications. In this study, protocols for surface‐crosslinked gelatin particles type A (GNP‐A) and B (GNP‐B) are described. Significant differences between the two types of gelatin are reported regarding their physicochemical and mechanical properties. GNP‐A consists of a lower crosslinking degree, leading to pronounced swelling in aqueous environments and softer nanoparticles. They possess contrary properties compared to the more extensively crosslinked and stiffer GNP‐B. However, this doesn't affect encapsulation efficiency, allowing to develop nanoparticulate systems suitable for various applications by adjusting the particle properties while maintaining the same drug load. These findings provide a deeper understanding of polymeric gelatin particles and reveal the importance of investigating the mechanical properties of drug delivery systems during pharmaceutical development.
- 23 September 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 24 (39) , 7072-7076
Stereoselective Synthesis of a Protected Side Chain of Callipeltin A
Matteson homologations of chiral boronic esters proved to be an excellent tool for the synthesis of highly functionalized amino and hydroxy acid residues. This method provides straightforward stereoselective access to the side chain of callipeltin A, a natural marine product with interesting biological activities. Furthermore, this protocol should allow for variations in the substitution pattern in future SAR studies, simply by choosing suitable nucleophiles during the homologation steps.
- 23 September 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 24 (39) , 7072-7076
Stereoselective Synthesis of a Protected Side Chain of Callipeltin A
Matteson homologations of chiral boronic esters proved to be an excellent tool for the synthesis of highly functionalized amino and hydroxy acid residues. This method provides straightforward stereoselective access to the side chain of callipeltin A, a natural marine product with interesting biological activities. Furthermore, this protocol should allow for variations in the substitution pattern in future SAR studies, simply by choosing suitable nucleophiles during the homologation steps.
- Open Access
- 23 August 2022
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (19) , 5213-5218
Synthesis of the cyclic heptapeptide core of callipeltin A
Macrolactonisation of a novel heptapeptide precursor with PyAOP proved to be an excellent method for preparation of the cyclic depsipeptide core of callipeltin A. The individual building blocks were obtained in high yield and selectivity and successive coupling allowed for the straightforward preparation of the linear heptapeptide from tyrosine 6 in 27% over 12 steps.
- 23 August 2022
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (19) , 5213-5218
Open AccessSynthesis of the cyclic heptapeptide core of callipeltin A
Macrolactonisation of a novel heptapeptide precursor with PyAOP proved to be an excellent method for preparation of the cyclic depsipeptide core of callipeltin A. The individual building blocks were obtained in high yield and selectivity and successive coupling allowed for the straightforward preparation of the linear heptapeptide from tyrosine 6 in 27% over 12 steps.